Prenatal exposure to the organophosphate insecticide chlorpyrifos enhances brain oxidative stress and prostaglandin E synthesis in a mouse model of idiopathic autism by unknown
RESEARCH Open Access
Prenatal exposure to the organophosphate
insecticide chlorpyrifos enhances brain
oxidative stress and prostaglandin E2
synthesis in a mouse model of
idiopathic autism
Alessia De Felice1,3, Anita Greco2, Gemma Calamandrei1 and Luisa Minghetti2*
Abstract
Background: Autism spectrum disorders (ASD) are emerging as polygenic and multifactorial disorders in which
complex interactions between defective genes and early exposure to environmental stressors impact on the
correct neurodevelopment and brain processes. Organophosphate insecticides, among which chlorpyrifos (CPF),
are widely diffused environmental toxicants associated with neurobehavioral deficits and increased risk of ASD
occurrence in children. Oxidative stress and dysregulated immune responses are implicated in both
organophosphate neurodevelopmental effects and ASD etiopathogenesis. BTBR T+tf/J mice, a well-studied model
of idiopathic autism, show several behavioral and immunological alterations found in ASD children, and we recently
showed that CPF gestational exposure strengthened some of these autistic-like traits. In the present study, we
aimed at investigating whether the behavioral effects of gestational CPF administration are associated with
brain increased oxidative stress and altered lipid mediator profile.
Methods: Brain levels of F2-isoprostanes (15-F2t-IsoP), as index of in vivo oxidative stress, and prostaglandin E2
(PGE2), a major arachidonic acid metabolite released by immune cells and by specific glutamatergic neuron
populations mainly in cortex and hippocampus, were assessed by specific enzyme-immuno assays in brain
homogenates from BTBR T+tf/J and C57Bl6/J mice, exposed during gestation to either vehicle or CPF.
Measures were performed in mice of both sexes, at different postnatal stages (PNDs 1, 21, and 70).
Results: At birth, BTBR T+tf/J mice exhibited higher baseline 15-F2t-IsoP levels as compared to C57Bl6/J mice,
suggestive of greater oxidative stress processes. Gestational treatment with CPF-enhanced 15-F2t-IsoP and PGE2
levels in strain- and age-dependent manner, with 15-F2t-IsoP increased in BTBR T+tf/J mice at PNDs 1 and 21,
and PGE2 elevated in BTBR T+tf/J mice at PNDs 21 and 70. At PND 21, CPF effects were sex-dependent being
the increase of the two metabolites mainly associated with male mice. CPF treatment also induced a reduction
of somatic growth, which reached statistical significance at PND 21.
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Conclusions: These findings indicate that the autistic-like BTBR T+tf/J strain is highly vulnerable to environmental
stressors during gestational period. The results further support the hypothesis that oxidative stress might be the
link between environmental neurotoxicants such as CPF and ASD. The increased levels of oxidative stress during
early postnatal life could result in delayed and long-lasting alterations in specific pathways relevant to ASD, of
which PGE2 signaling represents an important one.
Keywords: Autism spectrum disorders, BTBR mice, Isoprostanes, Prostaglandins, Lipid metabolism, Oxidative stress,
Neuroinflammation, Pesticides
Background
The etiological bases of the majority of human neurode-
velopmental disorders, including autism spectrum disor-
ders (ASD), are still unknown though a great body of
data supports their polygenic and multifactorial etiology
[1]. Substantial evidence indicates that ASD may derive
from the complex interaction between many defective
genes and early exposure to different environmental
stressors, which can alter the typical neurodevelopment
with consequent disruption of some behaviors [2].
Dysregulated immune responses and lipid metabolism
impairment, associated with enhanced oxidative stress,
are thought to contribute to etiopathogenesis of ASD
and other neurodevelopmental disorders [3–5]. In par-
ticular, some data suggest that alterations in lipid meta-
bolism, due to multiple causes, play an important role in
autism pathogenesis [6, 7]. Oxidative stress, a condition
defined as an alteration in the balance between pro-
oxidant and anti-oxidant molecules and associated with
long-term damage [8], is one of the plausible mecha-
nisms that link genes and environment. Several data
point to a key role of oxidative stress in human toxicity
of industrial chemicals, such as heavy metals and pes-
ticides [9–11]; in particular, induction of oxidative stress,
besides acetylcholinesterase (AChE) inhibition, is among
the main mechanisms mediating both acute and chronic
organophosphate (OP) pesticide exposure [9, 10, 12].
The human brain is composed predominantly by lipids;
polyunsaturated fatty acids (PUFAs) such as arachidonic
acid, eicosapentaenoic acid, and docosahexaenoic acid
are major constituents of the cell membranes. PUFAs
can be metabolized through different enzymatic path-
ways to generate lipid signaling messengers [13]. Among
them, prostaglandin E2 (PGE2), an arachidonic acid
metabolite of the cyclooxygenase (COX) pathway, is an
important lipid signaling messenger affecting many
immune and brain functions [14].
PUFAs are exquisitely sensitive to oxidative stress,
and broad range metabolites can be generated non-
enzymatically, by direct free radical attack of membrane
esterified PUFAs [15]. Among these lipid peroxidation
products, F2-isoprostanes, and in particular 15-F2t-Iso-
prostane (15-F2t-IsoP, also known as 8-isoprostane-F2α),
are considered reliable index of in vivo oxidative
stress. Of note, increased levels of 15-F2t-IsoP have
been detected in both red blood cells and urine samples
of children with autism compared to age-matched con-
trols [16]; later, El-Ansary and co-workers found elevated
plasma F2-isoprostanes in Saudi autistic children, to-
gether with alterations in lipid mediators such as PGE2
and leukotrienes [17].
Black and tan brachyury T+tf/J (BTBR) is an inbred
mouse strain that displays several behavioral traits rele-
vant to autism, such as impairments in social and com-
munication domains with lacks of sociability in social
approach tasks, reduction in the emission of ultrasonic
vocalizations in various social settings, and high levels of
repetitive behaviors [18]. Although well-studied, the
inherited genetic changes that lead to autistic-like beha-
viors in these mice are scarcely known and still under
active investigation [19–21]. BTBR mice show several of
the immunological alterations found in children with
ASD, such as an increased rate of immunological activa-
tion, with high levels of pro-inflammatory cytokines such
as IL-1β, IL-6, and TNF-α and increased number of
microglia at the adult stage [22, 23].
The link between immune system dysregulation and
behavioral deficits in ADS is not yet well understood,
and the BTBR mouse provides a well-established model
to further investigate this issue. Immune disturbances
found in this mouse strain might result in higher vul-
nerability to oxidative stress promoted by toxicants,
with possible more severe repercussions on neural
development, a hypothesis that has also called in to
explain the environmental contribution to autism risk
in children [24].
To test this hypothesis, in the present study, we
administered the OP pesticide chlorpyrifos (CPF) at the
sub-toxic dose of 6 mg/kg/body weight or vehicle to
pregnant mice of either C57 BL6/J (C57) or BTBR inbred
strains, by oral gavage, from gestational day (GD) 14 to
17, replicating as for dose and administration schedule
our previous studies performed in CD-1 outbred mice
[25, 26]. Among OP pesticides, CPF has recently been
listed as one of the environmental chemicals possibly
responsible for increased ASD risk in children [27].
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Specifically, epidemiological studies indicate that environ-
mentally relevant exposure in utero to CPF may affect
children’s neuropsychological maturation, in terms of
impaired reflex functioning in newborns [28, 29] and
decreased mental and psychomotor performances and
attention problems in infants, with higher risk to develop
pervasive developmental disorders [30]. In agreement with
human data, an increasing body of rodent data indicates
that, at sub-toxic doses, developmental exposure to CPF
affects neurobehavioral maturation, targeting neural and
neuroendocrine systems involved in ASD etiology
[31–35]. In the present study, C57 mice were used as
control strain since they present strong similarity with
BTBR mice as for gene background, but lack the
autism-like phenotype [19]. 15-F2t-IsoP and PGE2
were measured in the whole brain at postnatal day
(PND) 1 and 70 in the offspring of both sexes in the
two strains. The same parameters were measured at
weaning (PND 21) in the BTBR strain. BTBR mice
showed higher baseline levels of 15-F2t-IsoP at birth
as compared to C57 mice, suggestive of enhanced
oxidative stress processes. In line with our hypothesis,
gestational CPF treatment selectively enhanced oxida-
tive stress in BTBR mice at birth (PND 1) and wea-
ning (PND 21), whereas PGE2 levels were particularly
elevated at adulthood (PND 70).
Methods
Animals
Male and female mice of the BTBR and C57 strain
purchased from the Jackson Laboratory (Bar Harbour,
ME, USA) were housed upon arrival in breeding cages
(polycarbonate cages 33x13x14 cm) under standard
animal housing conditions (temperature 20 ± 2 °C;
humidity 60–70 %) with food (enriched standard diet for
mice from Altromin, Spezialfutter GmbH & Co.
Germany) and water ad libitum, under a 12:12 reverse
light cycle (lights on from 8:00 p.m. till 8:00 a.m.).
Females were inspected daily for the presence of the
vaginal plug (GD 0). On GD 14, pregnant females were
randomly assigned to one of the two prenatal treatments
(vehicle, CPF). CPF (Chem. Service, West Chester, PA)
was dissolved in peanut oil as vehicle to provide rapid
and complete absorption. CPF (in a volume of 0.1 ml/
10 g at a dose of 6 mg/kg/bw) or its vehicle was admi-
nistered to pregnant females from GD 14 to 17 by
intraoral gavage. The dose of CPF was originally selected
on the basis of previous multidose studies performed in
our laboratory in CD1 mice [26, 36, 37] as the more
effective one in producing behavioral changes in the
absence of overt toxic symptoms in dams or major
effects on pregnancy length, number of pups at delivery,
sex ratio, pups’ weight at delivery and growing rate. This
same dose was able to induce significant changes in early
motor development and amplification of the autism-like
behavioral traits in adult males in BTBR strain (see below).
A total of 31 litters (16 vehicle-treated and 15 CPF-
treated) were used. Females’ body weight was monitored
daily during pregnancy. Proportion of term pregnancies,
gestation length, litter size, sex ratio, and neonatal mor-
tality were also measured to exclude potential effects of
the treatment on reproductive performances. On the day
of birth, which is defined as PND 0, the sex of the pups
was assessed by evaluation of anogenital distance. One
pup of each sex was randomly selected from each litter
and sacrificed at either PND 1, PND 21 (BTBR only), or
PND 70 for the assessment of 15-F2t-IsoP and PGE2 in the
brain. The siblings of the BTBR mice used in the present
study formed the subjects of a different study aimed at
describing early and delayed effects of CPF on the beha-
vioral phenotype of BTBR mice [25]. At weaning (PND
21), male and female offspring were separated and main-
tained in same-sex pairs till the adulthood. Body weight of
each individual pup was recorded on PNDs 1, 4, 6, 8, and
12, at weaning (PND 21) and at adulthood (PND 70). In
addition, nine C57 mice and ten BTBR mice born from
mothers not receiving any treatment were used to mea-
sure the baseline levels of both 15-F2t-IsoP and PGE2 in
the two strains on the day of birth.
15-F2t-IsoP and PGE2 measurement
The levels of 15-F2t-IsoP were assessed as previously
described [38]. Briefly, brains were weighed and homo-
genized in 50-mM Tris buffer, pH 7.5 (1 mg/0.1 ml),
containing the anti-oxidant BHT (10 μM) and the COX
inhibitor indomethacin (1 μM) to block ex vivo arachi-
donic acid auto-oxidation and PGs formation. Homoge-
nates were vigorously vortexed and incubated for 5 min
on ice before centrifuging at 14,000 rpm for 45 min at
4 °C. Supernatants were collected and stored at −80 °C
until assayed. 15-F2t-IsoP was measured by a specific
competitive enzyme immunoassay (Cayman Chemical
Company, Ann Arbor, MI), according to the manu-
facturer’s instructions. Ellman’s reagent was used as a
substrate and absorbance measured at 405 nm using a
microplate reader (GDV DV990BV6). For quantification,
a standard curve was built with eight serial dilutions
ranging from 500 to 0.8 pg/ml and analysis performed
using four-parameter logistic fitting. Detection limit was
2 pg/ml; anti-15-F2t-IsoP antibody cross-reactivity with
other iso-prostaglandins was less than 0.15 %. PGE2
levels were measured by a competitive high sensitivity
enzyme immunoassay (sensitivity 8.25 pg/ml; Assay
Design, Inc., Ann Arbor, MI). A buffered solution of
p-nitrophenyl phosphate was used as substrate and ab-
sorbance measured at 405 nm with correction at 570 nm,
using a microplate reader (GDV DV990BV6). For quanti-
fication, a standard curve was built with eight serial
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dilution ranging from 1000 to 7.8 pg/ml and analysis
performed using four-parameter logistic fitting. Anti-PGE2
antibody cross-reactivity with other prostaglandins was less
than 1.5 %. Serial dilutions of samples were then tested, in
duplicate, for 15-F2t-IsoP and PGE2 content.
Statistical analysis
Data are expressed as means ± SEM of n independent
experiments (run in duplicate). Due to the large dif-
ference in baseline levels between birth and adulthood,
each age point was analyzed separately. Statistical signi-
ficance was evaluated applying factorial ANOVA with
strain (2 levels), treatment (2 levels), and sex (2 levels) as
fixed grouping factors. Multiple comparisons were per-
formed by the Tukey HSD test. Correlation coefficients
(rs) were calculated by Spearman’s rank correlation. p <
0.05 was accepted as statistical significance. Data were
analyzed using the Stata Tm 10 statistical package (Stata
Corporation, College Station, TX, USA).
Results
Brain levels of 15-F2t-IsoP and PGE2 in BTBR and C57BL6/J
newborn mice
Firstly, we compared brain levels of both 15-F2t-IsoP
and PGE2 at PND 1 in BTBR and C57 mice of both
sexes born to untreated mothers (Fig. 1). BTBR mice
showed higher 15-F2t-IsoP levels than C57 mice [main
effect of strain: F(1,14) = 20.607, p = 0.0005], suggesting
that, in line with the observations reported in ASD
children, BTBR mice are characterized by higher levels
of oxidative stress. PGE2 levels were not significantly
different between the two strains of mice, but they were
higher in female offspring of both strains [main effect of
sex: F(1,14) = 6.029, p = 0.027].
Effects of CPF prenatal exposure in BTBR and C57BL6/J
mice
In agreement with our previous studies, the selected
dose for CPF treatment (6 mg/kg/bw) did not affect
reproductive parameters such as gestation length, weight
gain of the pregnant females, and weight and viability of
the pups at birth, in both strains [25].
The effect of gestational CPF administration on brain
levels of 15-F2t-IsoP and PGE2 is shown in Fig. 2. As for
15-F2t-IsoP (Fig. 2a), at PND 1, ANOVA yielded a
significant effect of strain [F(1,31) = 17.519, p = 0.0002]
with BTBR mice showing higher levels of 15-F2t-Isop
than C57 mice and a significant two-way interaction
between strain and treatment [F(1,31) = 10.323, p =
0.0031]. BTBR mice prenatally exposed to CPF exhibited
increased levels of 15-F2t-IsoP as compared to vehicle-
exposed BTBR mice (p < 0.05 after post hoc compa-
risons), while CPF treatment tended to decrease 15-F2t-
IsoP brain levels in C57 strain (this difference just
missed statistical significance). Brain levels of PGE2 were
significantly higher in C57 than in BTBR mice (Fig. 2b)
[F(1,31) = 36.75, p < 0.0001] and were not influenced by
CPF treatment in either strain. In BTBR pups born to
vehicle-treated mothers, the levels of both 15-F2t-IsoP
and PGE2 were decreased as compared to the offspring
of untreated mothers (see Fig. 1), an effect that could be
related to reported higher susceptibility to handling
stress of BTBR than C57 mice [39]; the effect was,
however, transient, and no differences were appreciated
between offspring of naive and vehicle-treated mothers
at later time points (not shown).
At PND 70, we found a significant main effect of the
strain [F(1,26) = 9.947, p = 0.004] as BTBR mice had
higher levels of 15-F2t-IsoP than C57 mice, regardless
the treatment received during gestation (Fig. 2a, right
panel). PGE2 levels (Fig. 2b) were still higher in C57 than
in BTBR strain [main effect of strain F(1,24) = 13.18, p =
0.0013], but ANOVA yielded a significant interaction
between strain and treatment [F(1,24) = 6.329, p = 0.019],
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Fig. 1 Brain levels of 15-F2t-IsoP and PGE2 in untreated male and
female C57BL6/J and BTBR mice at PND 1. Levels of 15-F2t-IsoP or
PGE2 in brain homogenates are given as pg/mg of wet tissue and
are expressed as mean ± SEM (n = 4 males and 5 = females for both
BTBR and C57BL6/J)
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BTBR strain (p < 0.05 after post hoc comparisons) and a
decrease, which did not reach significance, in the C57
strain.
At PND1 and PND 70, there were no sex differences
for either 15-F2t-IsoP or PGE2 levels in both CPF- and
vehicle-exposed (BTBR or C57 groups, not shown).
Effects of CPF prenatal exposure in BTBR mice at PND 21
On the basis of above findings showing different profiles
of effects at the neonatal stage and adulthood in BTBR
mice only, we sought to further investigate the effect of
gestational CPF treatment in this strain at PND 21. This
age corresponds in laboratory mice to the adolescent
phase, namely to a critical transition point in which the
second wave of neuronal reorganization occurs, through
mechanisms of pruning to eliminate the synapses in
excess [40, 41]. We found that at this age, CPF treatment
significantly increased the levels of both 15-F2t-IsoP and
PGE2 (Fig. 2). For both 15-F2t-IsoP and PGE2, ANOVA
yielded a significant main effect of treatment at this age
[15-F2t-IsoP: F(1,10) = 11.468, p = 0.0069; PGE2: F(1,10)
= 12.309, p = 0.0056]. Furthermore, in the case of 15-F2t-
IsoP (Fig. 3a), a significant interaction between treat-
ment and sex [F(1,10) = 7.025, p < 0.024] evidenced that
the effect of CPF was limited to the male sex (p < 0.05
after post hoc comparisons). Since a similar trend was
observed also for PGE2, we decided to perform post hoc
comparisons on the interaction between sex and treat-
ment [F(1,9) = 2.486, p = 0.14], as the Tukey HSD test
can be used also in the absence of significant ANOVA
results [42]. We found that the effects of CPF were
limited to the male sex also in the case of PGE2 (p < 0.05
after comparison between vehicle and CPF within the
male group).
Effects of CPF prenatal exposure on somatic growth in
BTBR and C57BL6/J mice
In a previous study, we monitored the effect of CPF
prenatal exposure on somatic growth of BTBR mice
between PND 4 and 12, showing a negative trend and
significant effect at PND 12 [25]. As shown in Table 1,
body and brain weight of both C57 and BTBR mice
prenatally exposed to CPF was not significantly different
from that of vehicle-exposed mice at PND 1 and PND
70. At PND 21, body weight of BTBR mice prenatally
exposed to CPF was significantly lower than that of
vehicle-exposed mice at this age [F(1,12) = 10.99, p =


























































Strain effect p = 0.0002 
Strain effect p < 0.0001  
Strain effect p = 0.004
Strain effect p = 0.0013
Strain x treatment effect p = 0.0031 
Strain x treatment effect p = 0.019 
Fig. 2 Effects of CPF prenatal exposure on 15-F2t-IsoP and PGE2 brain levels in C57BL6/J and BTBR mice at PNDs 1, 21, and 70. Brain levels of
15-F2t-IsoP (a) and PGE2 (b) were measured in brain homogenates of C57BL6/J (PND 1 and 70) and BTBR mice (PND 1, 21, and 70) prenatally
exposed to CPF or vehicle from GD 14 to 17. Data are given as pg/mg of wet tissues and are expressed as mean ± SEM; *p < 0.05 significant
difference between vehicle and CPF treatment (n = 10–12 for BTBR and n = 6 for C57BL6/J).
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brain weight (Fig. 3b, right). When considering all three
ages, 15-F2t-IsoP and PGE2 brain levels and brain weights
in BTBR mice were positively correlated in both vehicle
(rs 0.57, p = 0.0011 and rs 0.60, p = 0.0003, respectively)-
and CPF-exposed mice (rs 0.76, p = 0.0000; rs 0.81, p =
0.0001, respectively). Similarly, in C57 mice, 15-F2t-IsoP
and PGE2 brain levels and brain weights were positively
correlated in both vehicle (rs 0.67, p = 0.017 and rs
0.68, p = 0.0153, respectively)- and CPF-exposed mice
(rs 0.84, p = 0.003; rs 0.7, p = 0.007, respectively).
Somatic and brain growth were similar in both sexes
(not shown).
Discussion
Raising evidence points to oxidative stress as a major
pathogenic mechanism shared by etiological determi-
nants of neurodevelopment disorders such as genetic
and environmental factors. Several data confirm that
induction of oxidative stress is a major contributor of
the overall toxicity of the OP pesticides [43]. In parti-
cular, acute exposure of adult rodents to high doses of
CPF has been reported to increase lipid peroxidation
and to decrease the levels of key enzymes implicated in
oxidative defenses [44–47]. However, recent epidemio-
logical evidence raised concern on the impact that the
prolonged exposure to apparently non-toxic doses of OP
in critical phases of brain maturation might have on
child’s neurodevelopment. Experimental models mimi-
cking the human exposure scenarios to this widely
diffused class of pesticides may be pivotal to elucidate
the mechanisms implicated in OP developmental neuro-
toxicity and identify novel biomarkers for risk assessment.
To the best of our knowledge, this is the first study
analyzing the effect of gestational exposure to a sub-
toxic dose of CPF on brain levels of 15-F2t-IsoP, a
reliable and sensitive marker of in vivo oxidative stress,
in mice, at birth and later stages corresponding to ado-
lescence and adulthood. In addition to 15-F2t-IsoP, we
evaluated the levels of PGE2, a lipid mediator involved in
inflammatory and immune responses but also control-
ling several physiological and pathological functions in
the brain and found altered in ASD.
Our findings indicate that at birth, BTBR mice, a vali-
dated model of idiopathic autism displaying both beha-
vioral and immunological deficits associated with ASD,
are characterized by increased brain levels of 15-F2t-IsoP
as compared to C57 mice, a strain with strong gene
background similarity but lacking of autism-like pheno-
type. Gestational exposure to CPF promoted the increase
of both 15-F2t-IsoP and PGE2 in BTBR mice but not in
C57 mice, suggesting an important strain-treatment inter-
action effect and a selective vulnerability of the BTBR
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Fig. 3 Effects of CPF prenatal exposure in male and female BTBR
mice at PND 21. Brain levels of 15-F2t-IsoP (a) and PGE2 (b) were
measured in brain homogenates of male and female BTBR mice
prenatally exposed to CPF or vehicle. Data are given as pg/mg of
wet tissues and are expressed as mean ± SEM; #p < 0.05 vs
vehicle-exposed mice (n = 6–8 per group)
Table 1 Somatic and brain growth in C57BL6/J and BTBR mice
prenatally exposed to CPF
C57BL6/J BTBR C57BL6/J BTBR
Body weight (g) Brain weight (mg)
PND 1 Vehicle 1.75 ± 0.052 1.61 ± 0.084 75 ± 5 66 ± 3
CPF 1.68 ± 0.097 1.67 ± 0.120 70 ± 9 63 ± 2
PND 21 Vehicle nt 14.30 ± 0.88 nt 157 ± 6
CPF nt 11.07 ± 1.05* nt 149 ± 6
PND 70 Vehicle 23.92 ± 1.76 30.71 ± 1.62 297 ± 18 327 ± 12
CPF 24.68 ± 1.69 29.4 ± 1.33 307 ± 8 317 ± 12
Data are means ± SEM (n = 10–12 for BTBR and n = 6–7 for C57BL6/J); *p < 0.05
versus vehicle-exposed BTBR mice at same PND
nt not tested
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Interestingly, the increase in 15-F2t-IsoP and PGE2
levels occurred with different temporal patterns, being
15-F2t-IsoP elevated at birth and at weaning and PGE2
levels not affected at birth but stably increased at wea-
ning and adulthood. This suggests that the occurrence
of oxidative stress in a specific temporal window in early
postnatal life might result in delayed permanent alte-
rations in specific molecular pathways relevant to ASD,
such as PGE2 signaling [6, 7, 17].
PGE2 is a major arachidonic acid metabolite, preferen-
tially formed during the enzymatic activity of COX-2
[48], the inducible COX isoform. Besides its well-known
role in inflammation, COX-2/PGE2 pathway plays im-
portant physiological functions. In normal brain, COX-2
is localized to excitatory glutamatergic neurons and its
expression is dependent on synaptic activity [49]. COX-2
expression is developmental regulated and in the neo-
cortex COX-2 positive neurons show a typical laminar
distribution that is heavily disrupted in subjects affected
by Rett syndrome, a neurodevelopmental disorder char-
acterized by a defective development of cortical neurons
[50]. It is tempting to speculate that the increased PGE2
levels after prenatal CPF exposure could reflect an ex-
acerbation of the functional abnormalities evidenced in
young/adult BTBR mice, which include widespread re-
ductions in cortical thickness and reduced fronto-
cortical metabolism [51].
In the only study measuring F2-IsoPs and PGE2 in rats
acutely exposed to CPF, the former were positively asso-
ciated with learning deficits induced by CPF [47].
Though the design of our present study does not allow
a direct correlation between the altered brain levels of
15-F2t-IsoP and PGE2 and autism-like behavioral, it is
worth noting that in the siblings of the experimental
subjects used in the current study, CPF gestational
exposure caused a significant delay in motor maturation
in the first 2 weeks of life and worsened some of the
autistic-like traits of BTBR mice at adulthood [25].
Anomalies in specific motor responses, common to
other mouse models of ASD, have been proposed as
early markers for ASD diagnosis [52–54] strengthening
the relevance of our findings [25].
In light of the strong prevalence of ASD and other
neurodevelopmental disorders in the male sex, it is worth
considering that the effects of CPF are of comparable
extent in the two sexes both at birth and at adulthood.
However, on PND 21, there is a significant sex effect, with
males displaying the highest levels of 15-F2t-IsoP and
PGE2. This observation supports a higher vulnerability of
males to prenatal exposure to CPF and is consistent with
sex differences in CPF behavioral effects, suggested by
epidemiological and experimental studies. Horton et al.
[55] found that male children were more susceptible than
females as for cognitive effects, and we reported higher
vulnerability of the male sex to developmental CPF effects,
particularly as far as early neonatal behavior patterns is
concerned [25].
A higher vulnerability of the male sex to adverse
conditions associated with oxidative stress is indicated
by a study in newborn twins, a human natural model
for studying fetal adaptation to suboptimal supply of
nutrients—the most likely cause of reduced fetal
growth—in which occurrence of oxidative stress has been
demonstrated. In this study, males displayed higher cord
blood levels of 15-F2t-IsoP than females; the observation
held true when comparing twins of unlike-sex pairs,
strongly suggesting that males are more exposed to oxida-
tive stress than their sisters when experiencing the same
“in utero” environmental challenge [56].
Strong evidence indicates that males are more sensi-
tive to early-life challenges, such as infection and ische-
mia, and it has been suggested that this may contribute
to sexual dimorphism evident in early-onset develop-
mental disorders, including autism ([57] and references
therein).
In line with our previous results [25], CPF-exposed
BTBR mice showed a reduced somatic growth in the
developmental phase. Both CPF-induced oxidative stress
and reduced body weight reached the apex at weaning,
to return to normal level at adulthood, suggesting that
reduced growth rate and increased brain oxidative stress
might be part of the same adaptive response to adverse
conditions during early phases of life. Although the effect
on somatic growth was similar in males and females, the
increase in brain oxidative stress was higher in males,
further supporting the particular vulnerability of the male
sex to developmental suboptimal conditions. The reduc-
tion in body weight resulting from CPF treatment at PND
21 in BTBR mice was not associated with a corresponding
reduction in brain weight, an observation that might
suggest a transient increase in brain size with respect to
body weight during the developmental phase. Interestingly,
a transient brain overgrowth has been reported in some
studies on ASD children ([58] and references therein), in
which overgrowth and neural dysfunctions have been sug-
gested to underlie some of the autistic symptoms.
Altogether, we show here that a widely diffused insec-
ticide reportedly implicated in increased risk of neuro-
motor and neuropsychological impairments in children
induces a transient up-regulation of an oxidative stress
biomarker and a permanent alteration in PGE2 pathway in
a validated mouse model of ASD. A possible limitation of
our study is the use of a single CPF dose. Importantly, the
CPF dose used in the current and previous studies is safe
with respect to reproductive performance of treated dams
(pregnancy length, number of pups at delivery, sex ratio);
it does not induce systemic toxicity in dams or major
effects on pup’s health, and it is below the threshold for
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inhibition of brain AChE in the mouse species [26, 59].
Our findings thus reinforce the growing evidence that
the developmental neurotoxicity of CPF is not strictly
or uniquely related to its anticholinesterase activity
[60]. However, there is an indication of potential non-
monotonic dose-response effects of gestational CPF
on behavioral functions [61]. Even within the range
of sub-toxic doses, in critical maturational phase, “higher”
doses may cause small and transient enhancement of
cholinergic neurotransmission: such event might be para-
doxically protective for the developing brain insofar that
compensatory mechanisms are called upon. Thus, we
cannot exclude that a lower dose of CPF would have evi-
denced a different pattern of effects in the two strains
considered.
Conclusions
In the last years, numerous studies have suggested
that immunological factors as well as increased suscep-
tibility to oxidative stress may contribute to the etiology
of ASD.
Our findings indicate that prenatal CPF exposure, at a
dose devoid of maternal or systemic toxicity, significantly
affects oxidative stress and PGE2 synthesis in a validated
mouse model of idiopathic autism. In the light of the
hypothesis associating oxidative stress, lipid metabolism
alterations, and ASD etiology in children, future work in
this mouse model of autism will help in elucidating the
mechanistic pathways linking exposure to a widely diffused
neurotoxicant such as CPF, neurodevelopment alterations,
and behavioral deficits.
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